Article in Toxins, 2020. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 5 papers.
0numbers the graph read from it
0cells of the map it votes in
5citing papers in PubMed
0.1field-weighted citation impact, top 42% of its field
1 · What the graph read from it
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
2 · The registry
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
3 · Its place in the literature
Who cites it
5 citing papers in PubMed, 7 citations in OpenAlex.
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
5 · Who and what money
Authors and funding
10 authors at 1 institution in 1 country.
Jason A JoynerDepartment of Pharmaceutical Sciences, College of Pharmacy, University of New Mexico Health Sciences Center, Albuquerque, NM 87131, USA.
Seth M DalyDepartment of Pharmaceutical Sciences, College of Pharmacy, University of New Mexico Health Sciences Center, Albuquerque, NM 87131, USA.ORCID 0000-0002-3532-8810
Julianne PeabodyDepartment of Molecular Genetics and Microbiology, School of Medicine, University of New Mexico Health Sciences Center, Albuquerque, NM 87131, USA.
Kathleen D TriplettDepartment of Pharmaceutical Sciences, College of Pharmacy, University of New Mexico Health Sciences Center, Albuquerque, NM 87131, USA.ORCID 0000-0002-4333-2211
Srijana PokhrelDepartment of Pharmaceutical Sciences, College of Pharmacy, University of New Mexico Health Sciences Center, Albuquerque, NM 87131, USA.
Bradley O ElmoreDepartment of Pharmaceutical Sciences, College of Pharmacy, University of New Mexico Health Sciences Center, Albuquerque, NM 87131, USA.
Diane AdebanjoDepartment of Molecular Genetics and Microbiology, School of Medicine, University of New Mexico Health Sciences Center, Albuquerque, NM 87131, USA.
David S PeabodyDepartment of Molecular Genetics and Microbiology, School of Medicine, University of New Mexico Health Sciences Center, Albuquerque, NM 87131, USA.
Bryce ChackerianDepartment of Molecular Genetics and Microbiology, School of Medicine, University of New Mexico Health Sciences Center, Albuquerque, NM 87131, USA.
Pamela R HallDepartment of Pharmaceutical Sciences, College of Pharmacy, University of New Mexico Health Sciences Center, Albuquerque, NM 87131, USA.ORCID 0000-0003-2367-3382
University of New Mexico · US
Funding
WOMEN'S CANCERS RESEARCH PROGRAMP30CA118100 · NCI · UNIVERSITY OF NEW MEXICO HEALTH SCIS CTR · PI Yolanda Sanchez · 2005 to 2026
$57.1M
UNM HSC Clinical and Translational Science CenterUL1TR001449 · NCATS · UNIVERSITY OF NEW MEXICO HEALTH SCIS CTR · PI CAMPEN, MATTHEW J, PANDHI, NANCY · 2015 to 2024
$36.9M
Unfolded Protein Response and Autophagy in T Helper Cell Effector FunctionP20GM121176 · NIGMS · UNIVERSITY OF NEW MEXICO HEALTH SCIS CTR · PI VOJO P DERETIC · 2017 to 2026
$24.9M
University of New Mexico Clinical and Translational Science CenterUL1TR000041 · NCATS · UNIVERSITY OF NEW MEXICO HEALTH SCIS CTR · PI LARSON, RICHARD S · 2012 to 2014
$9.8M
Vaccine-mediated control of bacterial virulence regulation and infectionR01AI145324 · NIAID · UNIVERSITY OF NEW MEXICO HEALTH SCIS CTR · PI DALY, SETH MICHAEL · 2019 to 2023
$2.0M
VLP-based Vaccines for Targeting Staphylococcus aureus Secreted Virulence FactorsR21AI114706 · NIAID · UNIVERSITY OF NEW MEXICO HEALTH SCIS CTR · PI HALL, PAMELA RANEL · 2015 to 2016
$416k
Inducing Immune Control of Bacterial Virulence RegulationR21AI131098 · NIAID · UNIVERSITY OF NEW MEXICO HEALTH SCIS CTR · PI HALL, PAMELA RANEL · 2017 to 2018
$411k
National Institute of Allergy and Infectious Diseases AI114706National Institute of Allergy and Infectious Diseases AI131098National Institute of Allergy and Infectious Diseases AI145324NCATS NIH HHS UL1 TR000041NCATS NIH HHS UL1 TR001449NCI NIH HHS P30 CA118100NIAID NIH HHS R01 AI145324NIAID NIH HHS R21 AI131098NIGMS NIH HHS GM121176
6 · The paper itself
Abstract
The pore-forming cytotoxin α-hemolysin, or Hla, is a critical
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.
Vaccination with VLPs Presenting a Linear Neutralizing Domain of · full record | OpenQuestion